Baird Downgrades Aprea (APRE) to Neutral on Trial Failure
Go back to Baird Downgrades Aprea (APRE) to Neutral on Trial Failure| Aperture Health, Inc. (NASDAQ: APRE) | Delayed: 0.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $0.08 | |||
| Open | $0.69 | 52 Week Low | $0.00 | |||
| Day High | $0.70 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $0.00 | |||
| Volume | 11,383 | |||||
